up to now several years, the united kingdom has witnessed a revolution in clinical excess weight‑decline solutions — within the introduction of semaglutide (Wegovy®) to the rising recognition of tirzepatide (Mounjaro®). Now, A different identify is drawing focus in both equally scientific and pub